SL32028: Advanced drug discovery
[Page last updated: 15 May 2025]
Academic Year: | 2025/26 |
Owning Department/School: | Department of Life Sciences |
Credits: | 10 [equivalent to 20 CATS credits] |
Notional Study Hours: | 200 |
Level: | Honours (FHEQ level 6) |
Period: |
|
Assessment Summary: | CWRI 50%, EXCB 50% |
Assessment Detail: |
|
Supplementary Assessment: |
|
Requisites: | Before taking this module you must have taken SL22024 or SL20008 or similar |
Learning Outcomes: |
On successful completion of this unit, the student should be able to:
|
Synopsis: | Develop an appreciation of current developments and challenges in drug discovery programmes in the pharmaceutical industry.
Demonstrate an ability to identify, analyse, interpret and evaluate research papers and presentations covering a specific area of current drug discovery.
Engage with a variety of scientific resources including seminars and primary studies.
Develop professional skills through presentation of your research as a written review, news and views article and infographic. |
Content: | Students will attend a series of seminars designed to provide an insight into the challenges of drug discovery and development. Guest lecturers from pharmaceutical companies will speak on various aspects of novel drug target identification and validation as well as current examples of drug discovery within the biomedical field. Students will carry out research to identify a novel drug target and summarise a new development in a News and Views article. Students will also be expected to develop cognitive and transferable skills through analysis and interpretation of recent research publications in pharmacology. |
Course availability: |
SL32028 is Optional on the following courses:Department of Life Sciences
|
Notes:
|